-
EP4077324
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4077324
| EP4077324 - NOVEL COMPOUNDS AND THEIR USE [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 23.09.2022 Database last updated on 02.11.2024 | |
| Former | The international publication has been made Status updated on 25.06.2021 | ||
| Former | unknown Status updated on 20.01.2021 | Most recent event Tooltip | 12.07.2024 | Amendment by applicant | Applicant(s) | For all designated states Debiopharm International S.A. Forum "après-demain" Chemin Messidor 5-7 1006 Lausanne / CH | [2022/50] |
| Former [2022/43] | For all designated states Debiopharm International SA Forum "après-demain" Chemin Messidor 5-7 1006 Lausanne / CH | Inventor(s) | 01 /
GERUSZ, Vincent 274A, chemin des confertes 74500 Neuvecelle / FR | 02 /
BRAVO, Juan Le Grand-Chemin 57 1066 Epalinges / CH | 03 /
PAULS, Heinz 112 Ontario St. Guelph, Ontario, N1E 3B2 / CA | 04 /
BERMAN, Judd 920 Birchview Drive Encinitas, California 92024 / US | 05 /
FINN, Terry 58 Boulevard St. Georges 1205 Geneva / CH | [2022/43] | Representative(s) | Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE | [2022/43] | Application number, filing date | 20838480.0 | 18.12.2020 | [2022/43] | WO2020EP87308 | Priority number, date | WO2019IB61119 | 19.12.2019 Original published format: PCT/IB2019/061119 | [2022/43] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2021123372 | Date: | 24.06.2021 | Language: | EN | [2021/25] | Type: | A1 Application with search report | No.: | EP4077324 | Date: | 26.10.2022 | Language: | EN | The application published by WIPO in one of the EPO official languages on 24.06.2021 takes the place of the publication of the European patent application. | [2022/43] | Search report(s) | International search report - published on: | EP | 24.06.2021 | Classification | IPC: | C07D471/04, C07D491/107, A61K31/551, A61K31/55, A61K31/04, A61P31/04 | [2022/43] | CPC: |
C07D471/04 (EP,IL,KR,US);
A61K31/55 (KR);
A61P31/04 (EP,IL,KR,US);
C07D491/107 (EP,IL,KR);
C07D519/00 (US);
Y02A50/30 (EP)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/43] | Extension states | BA | 19.07.2022 | ME | 19.07.2022 | Validation states | MA | 19.07.2022 | TN | 19.07.2022 | Title | German: | NEUARTIGE VERBINDUNGEN UND DEREN VERWENDUNG | [2022/43] | English: | NOVEL COMPOUNDS AND THEIR USE | [2022/43] | French: | NOUVEAUX COMPOSÉS ET LEUR UTILISATION | [2022/43] | Entry into regional phase | 19.07.2022 | National basic fee paid | 19.07.2022 | Designation fee(s) paid | 19.07.2022 | Examination fee paid | Examination procedure | 19.07.2022 | Examination requested [2022/43] | 19.07.2022 | Date on which the examining division has become responsible | 10.07.2024 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 27.12.2022 | Renewal fee patent year 03 | 27.12.2023 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [YD]WO2007067416 (AFFINIUM PHARM INC [CA], et al); | [Y]WO2008009122 (AFFINIUM PHARM INC [CA], et al); | [Y]WO2019177975 (UNIV ILLINOIS [US], et al) | by applicant | EP1726590 | WO2007067416 | WO2013042035 | WO2013190384 | WO2019177975 |